SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
02-Aug-24 5:28 PM View: | Processa Pharmaceuticals, I... (PCSA) | 10-Jul-24 | Payment of Exercise | 271 | $1.71 | $463.41 | (< 1%) 29.33K to 29.06K | |
02-Aug-24 5:28 PM View: | Processa Pharmaceuticals, I... (PCSA) | 10-Jul-24 | Option Exercise | 644 | -- | -- | 2% 28.69K to 29.33K | |
02-Aug-24 5:28 PM View: | Processa Pharmaceuticals, I... (PCSA) | 05-Apr-24 | Payment of Exercise | 539 | $2.79 | $1,503.81 | (2%) 29.23K to 28.69K | |
02-Aug-24 5:28 PM View: | Processa Pharmaceuticals, I... (PCSA) | 05-Apr-24 | Option Exercise | 1,675 | -- | -- | 6% 27.55K to 29.23K | |
01-Feb-24 6:32 PM View: | Processa Pharmaceuticals, I... (PCSA) | 01-Feb-24 | Purchase | 1,500 | $2.40 | $3,600.00 | 6% 25.98K to 27.48K | |
01-Feb-24 6:32 PM View: | Processa Pharmaceuticals, I... (PCSA) | 31-Jan-24 | Private Purchase | 2,500 | $2.37 | $5,925.00 | 11% 23.48K to 25.98K | |
12-Apr-24 4:55 PM View: | Processa Pharmaceuticals, I... (PCSA) | 01-Jan-24 | Payment of Exercise | 539 | $2.79 | $1,503.81 | (2%) 29.15K to 28.61K | |
12-Apr-24 4:55 PM View: | Processa Pharmaceuticals, I... (PCSA) | 01-Jan-24 | Option Exercise | 1,675 | -- | -- | 6% 27.48K to 29.15K | |
12-Oct-23 6:01 PM View: | Processa Pharmaceuticals, I... (PCSA) | 12-Oct-23 | Grant | 5,000 | $0.32 | $1,600.00 | 1% 464.54K to 469.54K | |
10-Oct-23 5:00 PM View: | Processa Pharmaceuticals, I... (PCSA) | 10-Oct-23 | Grant | 13,700 | $0.21 | $2,877.00 | 3% 450.83K to 464.54K | |
10-Feb-23 5:09 PM View: | Processa Pharmaceuticals, I... (PCSA) | 09-Feb-23 | Grant | 12,500 | $0.80 | $10,000.00 | 3% 438.33K to 450.83K | |
09-Aug-22 4:22 PM View: | Processa Pharmaceuticals, I... (PCSA) | 05-Aug-22 | Payment of Exercise | 2,656 | $3.17 | $8,419.52 | (< 1%) 440.99K to 438.33K | |
09-Aug-22 4:22 PM View: | Processa Pharmaceuticals, I... (PCSA) | 05-Aug-22 | Option Exercise | 7,601 | -- | -- | 2% 433.39K to 440.99K | |
19-May-22 6:11 PM View: | Processa Pharmaceuticals, I... (PCSA) | 17-May-22 | Private Purchase | 2,000 | $1.59 | $3,189.00 | < 1% 431.39K to 433.39K | |
08-Apr-22 4:49 PM View: | Processa Pharmaceuticals, I... (PCSA) | 07-Apr-22 | Purchase | 800 | $3.54 | $2,835.04 | < 1% 430.59K to 431.39K | |
08-Apr-22 4:49 PM View: | Processa Pharmaceuticals, I... (PCSA) | 06-Apr-22 | Private Purchase | 1,200 | $3.13 | $3,752.04 | < 1% 429.39K to 430.59K | |
16-Dec-21 4:37 PM View: | Processa Pharmaceuticals, I... (PCSA) | 14-Dec-21 | Market Purchase | 3,000 | $4.00 | $12,000.00 | < 1% 426.39K to 429.39K | 5% |
04-Jan-22 5:26 PM View: | Processa Pharmaceuticals, I... (PCSA) | 14-Dec-21 | Market Purchase Duplicate | 3,000 | $4.00 | $12,000.00 | < 1% 426.39K to 429.39K | 35% |
07-Dec-21 4:33 PM View: | Processa Pharmaceuticals, I... (PCSA) | 03-Dec-21 | Market Purchase | 3,500 | $4.80 | $16,795.10 | < 1% 422.89K to 426.39K | (5%) |
30-Aug-21 4:33 PM View: | Processa Pharmaceuticals, I... (PCSA) | 26-Aug-21 | Market Purchase | 4,000 | $6.02 | $24,088.00 | < 1% 418.89K to 422.89K | < 1% |
09-Aug-21 4:37 PM View: | Processa Pharmaceuticals, I... (PCSA) | 05-Aug-21 | Grant | 7,601 | -- | -- | 2% 411.29K to 418.89K | |
22-Jun-21 5:13 PM View: | Processa Pharmaceuticals, I... (PCSA) | 21-Jun-21 | Market Purchase | 2,000 | $6.65 | $13,300.00 | < 1% 399.74K to 401.74K | 5% |
05-Oct-20 4:42 PM View: | Processa Pharmaceuticals, I... (PCSA) | 01-Oct-20 | Purchase | 31,250 | $2.10 | $65,625.00 | 8% 368.49K to 399.74K |